AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Enristas 3 MF Tablet PR

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Enristas 3 MF Tablet PR

Diabexe Duo 3mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication aids in regulating blood glucose. Diabexe Duo 3mg should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart conditions should be disclosed to your physician before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) may be recommended.

Primary Ingredients of Enristas 3 MF Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Enristas 3 MF Tablet PR

Managing type 2 diabetes

Major Benefits of Enristas 3 MF Tablet PR:

Follow your physician's guidance or consult the product label for instructions. Administer Enristas 3 MF Tablet PR with a meal.

Common Side effects of Enristas 3 MF Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Enristas 3 MF Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Administer Enristas 3 MF Tablet PR with a meal.

How Enristas 3 MF Tablet PR works:

Enristas 3 MF Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Enristas 3 MF Tablet PR is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Enristas 3 MF Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Enristas 3 MF Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Enristas 3 MF Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Enristas 3 MF Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Enristas 3 MF Tablet PR :

Should you forget a dose of Enristas 3 MF Tablet PR, take it immediately if feasible. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Enristas 3 MF Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Enristas 3 MF Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Enristas 3 MF Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Enristas 3 MF Tablet PR and seek immediate medical attention.
Enristas 3 MF Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Enristas 3 MF Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Enristas 3 MF Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Enristas 3 MF Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Enristas 3 MF Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Enristas 3 MF Tablet PR
171
MRP 198
13% off